News Focus
News Focus
icon url

greatpick

12/29/13 9:16 AM

#15760 RE: NukeJohn #15758

NukeJohn I read fryeballs post on yahoo the only part that concerns me is this paragraph. Is this any thing to worry about or just a discloser. tia

20users liked this postsusers disliked this posts1Reply
Perrito said they have the license to 17 patents, 5 related to Anatabine, and 12 related to Star Cure. He said much depends on the FDA tobacco dept. measurements of harmful substances. However, independent analysts who are in agreement that Star's process removes many of the carcinogens are very hostile toward the tobacco industry and you know what kind of politics that ends up in. So for now, that's an issue that is simply in a holding tank.
Here's what I wrote about the Thyroiditis study--results were submitted, study was double blinded, placebo controlled and showed a significant decline in Thyroglobulin antibodies, this is the study that was published--all Endocrinologists involved were very please with outcomes...they also mentioned that CRP levels dropped significantly for individuals with or at risk of Diabetes which suggests that inflammation has dropped and reduces cardiac risk
icon url

LutherTiggs

12/29/13 11:56 AM

#15763 RE: NukeJohn #15758

You said,

"They appear to be ready to hit the ground running with upcoming investment conferences and discussions with Pharmas."

What exactly are you referring to there? I know they said they would have an investor update in Q1, but is there something else that you are specfically referring to?